Reuters: Moderna to seek U.S. and EU authorization for its vaccine on Monday

Moderna Inc will apply for U.S. and European emergency authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns, the company said, Reuters informed this Monday.   Moderna also reported that its vaccine’s efficacy rate was consistent across age, race, ethnicity and gender demographics as well as having a ...

Developed by Codecraftsman